These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24914397)

  • 1. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.
    Wang W; Zhao LR; Lin XQ; Feng F
    World J Gastroenterol; 2014 Jun; 20(21):6691-7. PubMed ID: 24914397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.
    Eryılmaz MK; Mutlu H; Salim DK; Musri FY; Coşkun HŞ
    J Oncol Pharm Pract; 2016 Dec; 22(6):806-810. PubMed ID: 26467267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Chang Y; Mbeo G; Littman SJ
    J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
    Ryan SA; Maceneaney P; O'Reilly SP; Moylan EJ; Power DG
    Med Oncol; 2012 Jun; 29(2):1287-91. PubMed ID: 21390516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible posterior leukoencephalopathy syndrome and trastuzumab.
    Kaneda H; Okamoto I; Satoh T; Nakagawa K
    Invest New Drugs; 2012 Aug; 30(4):1766-7. PubMed ID: 21633924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.
    Lou E; Turner S; Sumrall A; Reardon DA; Desjardins A; Peters KB; Sampson JH; Friedman HS; Vredenburgh JJ
    J Clin Oncol; 2011 Oct; 29(28):e739-42. PubMed ID: 21900098
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
    Maeda T; Kikuchi E; Matsumoto K; Yazawa S; Hagiuda J; Miyajima A; Nakagawa K; Fujiwara H; Hoshino H; Oya M
    Int J Clin Oncol; 2010 Oct; 15(5):508-11. PubMed ID: 20352464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.
    Levy CF; Oo KZ; Fireman F; Pierre L; Bania MA; Sadanandan S; Yamashiro DJ; Glade Bender JL
    Pediatr Blood Cancer; 2009 May; 52(5):669-71. PubMed ID: 19101996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient.
    Abbas O; Shamseddin A; Temraz S; Haydar A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23436889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.
    Dedić Plavetić N; Rakušić Z; Ozretić D; Simetić L; Krpan AM; Bišof V
    World J Surg Oncol; 2014 Aug; 12():264. PubMed ID: 25142792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior Reversible Encephalopathy Syndrome (PRES) Presenting as Status Epilepticus: A Case Report and Literature Review.
    Sharma P; Abbas MK; Huynh M
    Conn Med; 2016 Sep; 80(8):475-478. PubMed ID: 29782783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bevacizumab-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic colorectal cancer].
    Miyamoto S
    Nihon Shokakibyo Gakkai Zasshi; 2014 Apr; 111(4):743-7. PubMed ID: 24769463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
    Burnett MM; Hess CP; Roberts JP; Bass NM; Douglas VC; Josephson SA
    Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.
    Koopman M; Muller EW; Punt CJ
    Dis Colon Rectum; 2008 Sep; 51(9):1425-6. PubMed ID: 18470563
    [No Abstract]   [Full Text] [Related]  

  • 15. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
    Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
    Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.
    Bürki F; Badie K; Bartoli P; Bernard P; Montastruc JL; Bagheri H
    Br J Clin Pharmacol; 2008 May; 65(5):793-4. PubMed ID: 18279475
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible posterior leukoencephalopathy syndrome after carboplatin and paclitaxel regimen for lung cancer.
    Imai H; Okuno N; Ishihara S; Nakano S; Higuchi S; Arai T; Tokunaga M; Kobayashi H; Arai T; Mori M
    Intern Med; 2012; 51(8):911-5. PubMed ID: 22504249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible posterior leukoencephalopathy syndrome in cancer.
    Vaughn C; Zhang L; Schiff D
    Curr Oncol Rep; 2008 Jan; 10(1):86-91. PubMed ID: 18366965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome.
    Li Y; Gor D; Walicki D; Jenny D; Jones D; Barbour P; Castaldo J
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):873-82. PubMed ID: 21703874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
    Onujiogu N; Lengyel E; Yamada SD
    Gynecol Oncol; 2008 Dec; 111(3):537-9. PubMed ID: 18554701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.